Greater absolute benefit with PCSK9 inhibition in diabetes patients
3' education - July 3, 2018 - Prof. Kausik Ray, Imperial College London, UKEducational information
This 3-minute education provides a summary of presented scientific data at the ADA 2018. The objective is to provide a brief commentary and potential implications of these findings.
Faculty
Kausik Ray, MD, is a cardiologist, and Professor of Public Health/Honorary Consultant Cardiologist at Imperial College London, United Kingdom.
Disclosures
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: